The 3^rd mRNA-Based Therapeutics Summit returns to Boston this July, cementing its position as the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.

Download the event program here.

This year’s meeting promises 75+ deep-dive case studies from a speaker faculty that is 85% new for this year’s agenda, featuring presentations from the FDA, Pfizer, Moderna, BioNTech, Sanofi and many more.

Expect 100+ world-class speakers from large pharma, innovative biotechs, and key opinion leaders of academia, 5 dedicated tracks and 3 days of immersive content on discovery, translation, clinical development, chemistry, manufacturing and controls (CMC) and logistics to overcome industry hurdles of optimized dosing, targeted delivery, safety and scalability to achieve regulatory success in infectious and rare diseases, cancer and beyond!

Register your team here to join 500+ mRNA experts in July.